Dylan Scott
Senior Correspondent
Latest articles by Dylan Scott
The FDA’s controversial approval of a Biogen drug for Alzheimer’s disease could blunt future R&D, experts warn.
The Affordable Care Act is now a durable part of the American social safety net. Its successes and flaws have never been more apparent.
We’re about to learn a lot about how a public health insurance option actually works in the US.
Patients are desperate for hope. But there are serious concerns about Biogen’s new $56,000 treatment.
A new study challenges the conventional wisdom on why many doctors refuse to take Medicaid patients.
Which Covid-19 restrictions really worked — and which ones really didn’t?
A proposal to create a new public health insurance plan looked dead in Congress. It’s finally showing signs of life.
Employers are stepping up to support the US vaccination campaign. But they could do more.
A public health care option looks stalled in Congress. But it’s very much alive in Nevada.
4 million poor Americans are counting on Democrats to fix the Medicaid expansion gap.